鼻窦手术阿片类药物管理建议实施可行性研究
该单中心回顾性病例对照研究纳入163例接受功能性内镜鼻窦手术、鼻中隔成形术和/或下鼻甲减容术的患者,比较实施标准化疼痛控制方案前后阿片类药物处方量的变化。结果显示,以氢可酮当量(5 mg)计的平均阿片类药物处方量从方案前的24.59降至实施后的18.08(P < .001),而关于疼痛的术后电话呼叫次数和患者满意度评分无显著差异(P > .05)。
要点
- 多模式围手术期疼痛管理可减少鼻窦手术阿片类药物处方量。
- 以曲马多替代突破性疼痛未增加术后疼痛相关电话呼叫。
- 患者满意度评分未受阿片类药物管理方案影响。
核心结论
- 鼻窦手术可实施阿片类药物管理建议,包括多模式围手术期疼痛管理和以曲马多替代突破性疼痛,以减少阿片类药物处方量,而不增加患者电话呼叫或影响医生推荐Press Ganey评分的可能性。
研究设计与样本
- 单机构回顾性病例对照研究,纳入163例接受常规功能性内镜鼻窦手术、鼻中隔成形术和/或下鼻甲减容术的患者,比较实施基于已发表阿片类药物管理建议的标准化疼痛控制方案前后的情况。
主要发现
- 以氢可酮当量(5 mg)计的平均阿片类药物处方量从方案前的24.59降至实施新围手术期方案后的18.08(P < .001)。
- 两个时期之间关于疼痛的术后电话呼叫次数无显著差异(P > .05)。
- 两个时期之间患者满意度评分无显著差异(P > .05)。
关键数值与推荐
- 标准化方案包括术前至少30分钟口服加巴喷丁400 mg和对乙酰氨基酚1000 mg,术中采用浸有0.5%丁卡因的可吸收鼻腔填塞,术后使用对乙酰氨基酚和非甾体抗炎药,并处方曲马多片(50 mg)用于突破性疼痛。
临床怎么用
- 对于接受鼻窦手术的患者,可采用多模式围手术期疼痛管理方案和以曲马多替代突破性疼痛的阿片类药物管理策略,以减少阿片类药物处方量,同时不增加疼痛相关电话呼叫或降低患者满意度。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: The objective of our study was to review the current literature pertaining to perioperative opioids in sinus surgery and to determine the effects of implementing opioid stewardship recommendations in the setting of endoscopic sinonasal surgery. STUDY DESIGN: Single-institution retrospective case-control study. SETTING: Academic medical center outpatient area. METHODS: This retrospective review comprised 163 patients who underwent routine functional endoscopic sinus surgery, septoplasty, and/or inferior turbinate reduction before and after implementation of a standardized pain control regimen based on published opioid stewardship recommendations. The regimen consisted of an oral dose of gabapentin (400 mg) and acetaminophen (1000 mg) at least 30 minutes prior to surgery, absorbable nasal packing soaked in 0.5% tetracaine intraoperatively, and a postoperative regimen of acetaminophen and nonsteroidal anti-inflammatory medications. Tramadol tablets (50 mg) were prescribed postoperatively for breakthrough pain. The primary outcome measure for the study was the average number of hydrocodone equivalents (5 mg) prescribed before and after the new protocol. RESULTS: The average number of opioid medications prescribed, measured as hydrocodone equivalents (5 mg), decreased from 24.59 preprotocol to 18.08 after the initiation of the new perioperative regimen (P < .001). There was no significant difference between the periods (P > .05) in number of postoperative phone calls regarding pain or in patient satisfaction scores. CONCLUSION: Opioid stewardship recommendations can be instituted for sinonasal surgery, including multimodal perioperative pain management and substitution of tramadol for breakthrough pain, as a method to decrease the volume of opioids prescribed, without increasing patient phone calls or affecting the likelihood of physician recommendation Press Ganey scores.
引用
- Jordan JW, Spankovich C, Stringer SP, et al. Feasibility of Implementing Opioid Stewardship Recommendations for Sinonasal Surgery. Otolaryngol Head Neck Surg. 2020. PMID: 33138720. doi:10.1177/0194599820969155
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。